Twin Health stock
Private-market facts for current and former Twin Health employees researching their stock.
Overview
Digital health company using AI-powered digital twin technology to help reverse chronic metabolic diseases like type 2 diabetes through personalized recommendations.
Twin Health outlook
For employees evaluating Twin Health equity, a 1x base multiple suggests the stock may be close to fairly valued at current prices. The upside scenario at 2x is relatively close to the base case, suggesting more predictable but narrower range of outcomes.
These estimates reflect modeled return scenarios, not guaranteed outcomes. Actual results depend on company performance, market conditions, share class, and timing.
Selling Twin Health shares
Why shareholders consider selling
Shareholders in Twin Health may explore liquidity for a number of reasons — diversifying a concentrated position, funding a personal financial goal, or simply reducing exposure to a single private holding. As a private company, Twin Health does not trade on a public exchange, meaning employees and early shareholders cannot simply sell through a brokerage. Extended private timelines can leave shareholders waiting years for an exit event, which is why some choose to explore secondary-market options.
Can you sell Twin Health stock?
Whether a shareholder can sell typically depends on what they hold and how it was acquired. Vested and exercised shares are generally more straightforward than unexercised options or unvested RSUs. Most private companies, including those in the Healthcare & Biotech sector, impose transfer restrictions such as rights of first refusal or board approval requirements. The specific terms governing Twin Health shares would be outlined in the holder's equity agreement or the company's governing documents.
What affects the value of Twin Health shares?
The price a buyer is willing to pay for private shares is shaped by several factors: overall demand for the stock, the company's financial performance, broader Healthcare & Biotech market conditions, and any recent private-market transaction activity. Data points such as the company's Series D round can help frame expectations, though they do not guarantee a transaction price.
What should holders check before selling
- The type of security held (common shares, preferred, options, RSUs)
- Whether the equity is fully vested and, for options, whether it has been exercised
- Any transfer restrictions, lock-up provisions, or company approval requirements
- Estimated net proceeds after applicable taxes and transaction fees
- Whether partial liquidity — selling a portion rather than the full position — may be a better fit
Tools for Twin Health shareholders
Exploring equity in Twin Health often raises questions about taxes, exercise timing, valuation, and exit outcomes. These tools can help you model different decisions using your own assumptions.
Latest funding round
Twin Health most recently raised a Series D round . Total funding raised to date is approximately $141M.
Lead investors in this round include ICONIQ Capital and Sequoia Capital.
Founders & company background
Twin Health was founded in 2018 by Jahangir Mohammed and is headquartered in Mountain View, CA.
Investors
Industry
Similar private companies
Latest Twin Health news
Frequently asked questions
- Is Twin Health still a private company?
- Yes, Twin Health is currently a private company.
- What is Twin Health's latest funding round?
- Twin Health's most recent known round is Series D.
- What is Twin Health's valuation?
- Twin Health's valuation has not been publicly disclosed.
- Who are the investors in Twin Health?
- Notable investors include ICONIQ Capital, Sequoia Capital.
- Can I sell my Twin Health stock?
- Private company shares can sometimes be sold on secondary markets. Speaking with a specialist who understands Twin Health stock can help you evaluate your options.
Related pages
Last verified: 2026-04-13 · Twin Health data compiled from funding disclosures, investor announcements, corporate filings, and public records.
Information on this page is compiled from publicly available sources and may be outdated or incomplete. This is not investment advice. Consult a qualified advisor before making financial decisions.